KLRK1 and neoplasm: NKG2D is the receptor for MHC class I-related chain A and B (MICA/B) and UL16-binding proteins 1–6 (ULBP1-6), which are restrictedly expressed in benign cells, but are up-regulated in stressed and transformed cells, triggering a potent anti-tumour immune response [10]–[12].